SEC Filings | 4D pharma plc

Filing date	Form	Description	View
10 Jan 2022	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001493152-22-000790.pdf 0001493152-22-000790.rtf
10 Jan 2022	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001493152-22-000792.pdf 0001493152-22-000792.rtf
05 Jan 2022	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-22-000437.pdf 0001493152-22-000437.rtf 0001493152-22-000437.xls
14 Dec 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-031369.pdf 0001493152-21-031369.rtf 0001493152-21-031369.xls
14 Oct 2021	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001493152-21-025441.pdf 0001493152-21-025441.rtf 0001493152-21-025441.xls
14 Oct 2021	EFFECT	EFFECT	View HTML 9999999995-21-003879.pdf 9999999995-21-003879.rtf 9999999995-21-003879.xls
12 Oct 2021	CORRESP	CORRESP	View HTML 0001493152-21-025204.pdf 0001493152-21-025204.rtf 0001493152-21-025204.xls
07 Oct 2021	F-1/A	This filing is a pre-effective amendment to an F-1 filing	View HTML 0001493152-21-024858.pdf 0001493152-21-024858.rtf 0001493152-21-024858.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
01 Oct 2021	POS AM	Post-effective amendment to an S-Type filing	View HTML 0001493152-21-024243.pdf 0001493152-21-024243.rtf 0001493152-21-024243.xls
01 Oct 2021	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	View HTML 0001493152-21-024262.pdf 0001493152-21-024262.rtf 0001493152-21-024262.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.